Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes

BACKGROUND: In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their...

Descripción completa

Detalles Bibliográficos
Autores principales: van Paassen, Judith, Vos, Jeroen S., Hoekstra, Eva M., Neumann, Katinka M. I., Boot, Pauline C., Arbous, Sesmu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735177/
https://www.ncbi.nlm.nih.gov/pubmed/33317589
http://dx.doi.org/10.1186/s13054-020-03400-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735177/
https://www.ncbi.nlm.nih.gov/pubmed/33317589
http://dx.doi.org/10.1186/s13054-020-03400-9

Ejemplares similares